Company IXICO plc

Equities

IXI

GB00BFXR4C20

Biotechnology & Medical Research

Delayed London S.E. 02:59:59 2024-06-25 EDT 5-day change 1st Jan Change
7.25 GBX 0.00% Intraday chart for IXICO plc +12.40% -42.00%

Business Summary

IXICO plc is a United Kingdom-based medical imaging advanced analytics company. The Company is engaged in delivering insights in neuroscience to help transform the advancement of investigational therapies for neurological diseases, such as Huntington's disease, Parkinson's disease and Alzheimer's disease. It advances medicine and human health by turning data into clinically meaningful information, providing new insights in neuroscience by supporting pharmaceutical companies across all phases of central nervous system (CNS) clinical research. Its services include the collection, analysis, management, and reporting on data generated in the course of a clinical study. Its data platforms include TrialTracker and Assessa. The TrialTracker platform provides a secure and compliant environment for the collection, analysis and interpretation of large image files and other data. Its neuroimaging biomarkers focus area includes Radiological Reads, Volumetric MRI, PET and SPECT, and Advanced MRI.

Number of employees: 89

Sales per Business

GBP in Million2022Weight2023Weight Delta
Clinical Trials Services
100.0 %
9 100.0 % 7 100.0 % -22.89%

Sales per region

GBP in Million2022Weight2023Weight Delta
United States
45.8 %
3 31.4 % 3 45.8 % +12.62%
United Kingdom
14.3 %
2 23.8 % 1 14.3 % -53.72%
Netherlands
12.9 %
0 5.0 % 1 12.9 % +97.71%
Switzerland
12.2 %
2 24.0 % 1 12.2 % -60.71%
Ireland
10.3 %
1 8.4 % 1 10.3 % -4.83%
Europe
4.4 %
1 7.4 % 0 4.4 % -54.08%

Managers

Managers TitleAgeSince
Chief Executive Officer 63 17-02-05
Director of Finance/CFO 47 19-05-30
Chairman 59 13-10-13
Chief Operating Officer - -
Chief Tech/Sci/R&D Officer - 20-12-31
Chief Tech/Sci/R&D Officer 45 11-12-31

Members of the board

Members of the board TitleAgeSince
Chairman 59 13-10-13
Director/Board Member 49 16-09-15
Director/Board Member 60 23-10-04
Chief Executive Officer 63 17-02-05
Director of Finance/CFO 47 19-05-30
Director/Board Member 57 22-01-20

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 48,351,373 24,741,986 ( 51.17 %) 0 51.17 %

Shareholders

NameEquities%Valuation
BGF Investment Management Ltd.
18.46 %
8,924,000 18.46 % 795 307 p
Octopus Investments Ltd.
13.25 %
6,408,400 13.25 % 571 117 p
Gresham House Asset Management Ltd.
10.69 %
5,166,972 10.69 % 460 481 p
Canaccord Genuity Wealth Ltd.
9.685 %
4,683,071 9.685 % 417 355 p
Amati Global Investors Ltd. (Venture Capital)
9.612 %
4,647,697 9.612 % 414 203 p
CFE (UK) Ltd.
7.978 %
3,857,566 7.978 % 343 786 p
Hargreaves Lansdown Asset Management Ltd.
5.499 %
2,659,000 5.499 % 236 970 p
City Asset Management Plc
2.953 %
1,427,860 2.953 % 127 251 p
Hardsteel Ltd.
1.752 %
847,000 1.752 % 75 485 p
626,000 1.295 % 55 789 p

Company contact information

Ixico Plc

Griffin Court 15 Long Lane

EC1A 9PN, London

+44 20 3763 7499

http://www.ixico.com
address IXICO plc(IXI)